Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnosine for Peripheral Vascular Disease
NCT03844113Phase 2Unknown
- Sponsor
- Monash University
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carnosine in peripheral vascular disease (PVD), sponsored by Monash University. Primary endpoint: 6-minute walk test at 6 months. Status: unknown.
02
Drugs
carnosine
03
Conditions
peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT03844113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844113.